Advisor Group Holdings, Inc. Protalix Bio Therapeutics, Inc. Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 700 shares of PLX stock, worth $1,666. This represents 0.0% of its overall portfolio holdings.
Number of Shares
700
Previous 200
250.0%
Holding current value
$1,666
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding PLX
# of Institutions
68Shares Held
8.65MCall Options Held
168KPut Options Held
31.4K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.62MShares$3.84 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL1.08MShares$2.57 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA826KShares$1.97 Million0.0% of portfolio
-
Connor, Clark & Lunn Investment Management Ltd.496KShares$1.18 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA485KShares$1.15 Million0.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $118M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...